Dichloroacetate and cancer: new home for an orphan drug?
S Kankotia, PW Stacpoole - Biochimica et Biophysica Acta (BBA)-Reviews …, 2014 - Elsevier
We reviewed the anti-cancer effects of DCA, an orphan drug long used as an investigational
treatment for various acquired and congenital disorders of mitochondrial intermediary …
treatment for various acquired and congenital disorders of mitochondrial intermediary …
[HTML][HTML] Biomarker discovery in human prostate cancer: an update in metabolomics studies
AR Lima, M de Lourdes Bastos, M Carvalho… - Translational …, 2016 - Elsevier
Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading
cause of cancer death among men in Western countries. Current screening techniques are …
cause of cancer death among men in Western countries. Current screening techniques are …
NMR-based metabolomics strategies: plants, animals and humans
JGM Pontes, AJM Brasil, GCF Cruz, RN de Souza… - Analytical …, 2017 - pubs.rsc.org
Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful analytical platform
employed to address a diversity of issues of research such as in understanding chemical …
employed to address a diversity of issues of research such as in understanding chemical …
[HTML][HTML] Transcriptomic, proteomic and metabolomic profiling unravel the mechanisms of hepatotoxicity pathway induced by triphenyl phosphate (TPP)
Triphenyl phosphate (TPP) has been found in various environmental media and in biota
suggesting widespread human exposure. However, there is still insufficient information on …
suggesting widespread human exposure. However, there is still insufficient information on …
[HTML][HTML] In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH …
Dichloroacetate (DCA) can reverse the glycolytic phenotype that is responsible of increased
lactate production and extracellular pH acidification in cancer cells. Magnetic resonance …
lactate production and extracellular pH acidification in cancer cells. Magnetic resonance …
MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors
SS Pereira, MP Monteiro, MM Costa… - Journal of cellular …, 2019 - Wiley Online Library
Unraveling molecular mechanisms that regulate tumor development and proliferation is of
the utmost importance in the quest to decrease the high mortality rate of adrenocortical …
the utmost importance in the quest to decrease the high mortality rate of adrenocortical …
[HTML][HTML] Heterogeneous expression and subcellular localization of pyruvate dehydrogenase complex in prostate cancer
CE Nunes-Xavier, J Mingo, M Emaldi… - Frontiers in …, 2022 - frontiersin.org
Background Pyruvate dehydrogenase (PDH) complex converts pyruvate into acetyl-CoA by
pyruvate decarboxylation, which drives energy metabolism during cell growth, including …
pyruvate decarboxylation, which drives energy metabolism during cell growth, including …
Serum metabolomics of Indian women with polycystic ovary syndrome using 1 H NMR coupled with a pattern recognition approach
Polycystic ovary syndrome (PCOS) is one of the most commonly occurring metabolic and
endocrinological disorders affecting women of reproductive age. Metabolomics is an …
endocrinological disorders affecting women of reproductive age. Metabolomics is an …
[HTML][HTML] In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system …
DO Kamson, V Chinnasamy, SA Grossman… - Frontiers in …, 2023 - frontiersin.org
The adverse effects of lactic acidosis in the cancer microenvironment have been
increasingly recognized. Dichloroacetate (DCA) is an orally bioavailable, blood brain barrier …
increasingly recognized. Dichloroacetate (DCA) is an orally bioavailable, blood brain barrier …
[HTML][HTML] Pharmacometabolomics applied to personalized medicine in urological cancers
F Amaro, M Carvalho, ML Bastos, P Guedes de Pinho… - Pharmaceuticals, 2022 - mdpi.com
Prostate cancer (PCa), bladder cancer (BCa), and renal cell carcinoma (RCC) are the most
common urological cancers, and their incidence has been rising over time. Surgery is the …
common urological cancers, and their incidence has been rising over time. Surgery is the …